logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

MEGA GENOMICS (06667) repurchased 92,000 shares for approximately HK$656,200 on September 29.

date
20:20 29/09/2026
avatar
GMT Eight
MEGA GENOMICS (06667) announced that on September 29, 2026, the company repurchased 92,000 shares for approximately HK$656,200, at a repurchase price of HK$6.96 to HK$7.15 per share.
MEGA GENOMICS (06667) announced that on September 29, 2026, the company repurchased 92,000 shares for approximately HK$656,200, at a repurchase price of HK$6.96 to HK$7.15 per share.
Related Articles
HK Stock
LIVZON PHARMA (01513): Abnormal Fluctuations in A-Share Trading; No Major Matters That Should Be Disclosed but Have Not Been Disclosed
HK Stock
CF PHARMTECH (02652) repurchased 67,900 shares for HKD 489,100 on September 29.
HK Stock
ART GROUP HOLD (00565) issues profit warning, expects annual loss attributable to shareholders of not more than HK$17 million, turning from profit to loss year-on-year.
LIVZON PHARMA (01513): Abnormal Fluctuations in A-Share Trading; No Major Matters That Should Be Disclosed but Have Not Been Disclosed
HK Stock
CF PHARMTECH (02652) repurchased 67,900 shares for HKD 489,100 on September 29.
HK Stock
ART GROUP HOLD (00565) issues profit warning, expects annual loss attributable to shareholders of not more than HK$17 million, turning from profit to loss year-on-year.
HK Stock
RECOMMEND
Why ATGL's Small Scale Could Become an Advantage in Enterprise AI
Why ATGL's Small Scale Could Become an Advantage in Enterprise AI
icon
25/09/2026
From IT Services to Enterprise AI: What ATGL Must Prove Next
From IT Services to Enterprise AI: What ATGL Must Prove Next
icon
24/09/2026
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
icon
22/09/2026
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.